Loading…

Haemonetics Corporation acquired Vivasure Medical Limited, a Galway, Ireland-based developer of percutaneous vessel closure technology, for an upfront cash payment of €100 million plus up to €85 million in contingent consideration.
“Haemonetics Corporation...today announced the acquisition of Vivasure Medical Limited.”prnewswire.com
Summarized from public sources; check the original articles before acting on it.